KLOW (BPC-157 + TB-500 + GHK-Cu + KPV)
Blend · By Preptide Pro editorial team · Last updated
KLOW (BPC-157 + TB-500 + GHK-Cu + KPV) is a blend of BPC-157, TB-500 (Thymosin beta-4 fragment), GHK-Cu, KPV, and it is not FDA-approved as a combination. A combination of BPC-157, TB-500 (Thymosin beta-4 fragment), GHK-Cu and KPV. No combined product is FDA-approved, and research on the combination is limited. See each component for its own sources.
Not FDA-approved (as a combination)What is in KLOW (BPC-157 + TB-500 + GHK-Cu + KPV)?
| Component | Category | FDA status |
|---|---|---|
| BPC-157 | Tissue repair | Not FDA-approved |
| TB-500 (Thymosin beta-4 fragment) | Tissue repair | Not FDA-approved |
| GHK-Cu | Skin & repair | Not FDA-approved |
| KPV | Anti-inflammatory | Not FDA-approved |
Is KLOW (BPC-157 + TB-500 + GHK-Cu + KPV) FDA-approved?
Not FDA-approved (as a combination). No matching NDA or BLA was found in openFDA (Drugs@FDA).
Sources
This is general research information, not medical advice. Check with a clinician before using any compound.